Clinical trials
Leukemia, Myeloid, Chronic-Phase trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 7 |
| Fred Hutchinson Cancer Center | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| Novartis Pharmaceuticals | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Children's Oncology Group | 1 |
| Enliven Therapeutics | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Niguarda Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Chronic-Phase | 29 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 11 |
| Hodgkin Disease | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Leukemia, Myeloid, Accelerated Phase | 9 |
| Leukemia, Myeloid, Acute | 9 |
| Lymphoma, Large B-Cell, Diffuse | 9 |
| Lymphoma, Mantle-Cell | 9 |
| Multiple Myeloma | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
Trials
Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.